Engineered bacteriophages for therapeutic applications

Categories:

Pharmaceuticals and Biotechnology

Technology

This innovative platform leverages engineered bacteriophages to modulate the gut microbiome, targeting both infectious diseases and gut-microbiota-related disorders. These engineered phages offer a precision-targeted approach, interacting with bacterial communities in the gut microbiome to fine-tune microbe-host interactions and improve health outcomes.

Advantages

  • Precision-targeted therapy avoiding microbiota collateral damage.
  • Minimized bacterial resistance risk by targeting specific phenotypes
  • Addresses versatile applications such as gut and immune diseases.

Applications & Opportunities

  • Gut health therapeutics
  • Infectious disease management as alternative to antibiotics
  • Psychiatric & neurological disorders by targeting gut-brain axis conditions
  • Immune system modulation
  • Research applications
arrow Business Development Contacts
Dr. Mor Goldfeder
Director of Business Development, life Sciences